STAAR Surgical Co

STAA ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010
Revenue $55.0M
Cost of Revenue $19.9M
Gross Profit $35.1M
Gross Margin 63.8%
Operating Expenses
Research & Development $5.7M
SG&A Expense $14.8M
Operating Income $-2.6M
Operating Margin -4.7%
Interest Expense $896.0K
Pretax Income $-3.7M
Income Tax Expense $432.0K
Net Income $53.0K
Net Margin 0.1%
EPS (Basic) $0.00
EPS (Diluted) $0.00
Shares Outstanding (Basic) 34.8M
Shares Outstanding (Diluted) 34.8M
Dividends Per Share
← Newer Page 3 of 3 Older →